[1]郭爱灵,姚涛,潘斯庆,等.复方葛根素水飞蓟宾固体分散体的制备及表征[J].中国中医药信息杂志,2020,27(2):59-63.[doi:10.3969/j.issn.1005-5304.2020.02.201903393]
 GUO Ailing,YAO Tao,et al.Preparation and Characterization of Compound Puerarin Silybin Solid Dispersions[J].zhongguo zhongyiyao xinxi zazhi,2020,27(2):59-63.[doi:10.3969/j.issn.1005-5304.2020.02.201903393]
点击复制

复方葛根素水飞蓟宾固体分散体的制备及表征

参考文献/References:

[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.酒精性肝病防治指南(2018年更新版)[J].实用肝脏病杂志,2018,21(2):170-176.

[2] BARVE A, KHAN R, Marsano L, et al. Treatment of alcoholic liver disease[J]. Ann Hepatol,2008,7(1):5-15.

[3] European Association for the Study of Liver. EASL clinical practical guidelines:managemen to falcoholic liver disease[J]. J Hepatol,2012,57(2):399-420.

[4] TILG H, DAY C P. Management strategies in alcoholic liver disease[J]. Nat Clin Pract Gastroenterol Hepatol,2007,4(1):24-34.

[5] 徐立.葛根解酒液和葛根素对大鼠酒精性肝病治疗作用的研究[M].成都:四川大学,2007.

[6] CHEN X, LI R, LIANG T, et al. Puerarin improves metabolic function leading to hepatoprotective effects in chronic alcohol-induced liver injury in rats[J]. Phytomedicine,2013, 20(10):849-852.

[7] LI R, LIANG T, HE Q L, et al. Puerarin, isolated from Kudzu root (Willd.), attenuates hepatocellular cytotoxicity and regulates the GSK-3β/NF-κB pathway for exerting the hepatoprotection against chronic alcohol-induced liver injury in rats[J]. International Immunopharmacology,2013,17(1):71-78.

[8] 李鑫,王晨,王洪岩,等.水飞蓟宾治疗酒精性肝病疗效的Meta分析[J].实用肝脏病杂志,2014,17(1):22-25.

[9] ZHOLOBENKO A, MODRIANSKY M. Silymarin and its constituents in cardiac preconditioning[J]. Fitoterapia,2014,97(5):122-132.

[10] BOSCH-BARRERA J, MENENDEZ J A. Silibinin and STAT3:A natural way of targeting transcription factors for cancer therapy[J] Cancer Treatment Reviews,2015,41(6):540-546.

[11] 常跃兴,郭爱灵,陈铎葆,等.样品处理方法对皖南葛根和粉葛中总黄酮和葛根素含量的影响[J].中国中医药信息杂志,2017,24(11):45-41.

[12] 郭爱灵,姚斯琪,姚涛,等.正交设计优选葛根超声加热提取工艺[J].中国中医药现代远程教育,2019,17(2):107-110.

相似文献/References:

[1]周琴妹,丁琪.痤疮灵颗粒的定性定量标准研究[J].中国中医药信息杂志,2010,17(10):43.[doi:10.3969/j.issn.1005-5304.2010.10.018]
 ZHOU Qin-mei,DING Qi.Study on Qualitative and Quantitative Standard of Cuochuangling Keli[J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):43.[doi:10.3969/j.issn.1005-5304.2010.10.018]
[2]孔建平,孔小云.心可舒和葛根素治疗不稳定型心绞痛临床观察[J].中国中医药信息杂志,2007,14(1):74.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):74.
[3]张裕强,朱华旭,郭立玮.葛黄活血胶囊质量控制标准研究[J].中国中医药信息杂志,2008,15(3):53.
 ZHANG Yu-qiang,ZHU Hua-xu,GUO Li-wei.Study on the Quality Control Standard of Gehuang Huoxue Capsules[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):53.
[4]解克芳,王继峰,牛建昭.葛根素对人胚肺成纤维细胞增殖及细胞外基质合成的影响[J].中国中医药信息杂志,2008,15(5):39.
 XIE Ke-fang,WANG Ji-feng,NIU Jian-zhao.Effects of Puerarin on Proliferation of Human Embro Fibroblast Proliferation and Extracelluar Matrix in Vitro[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):39.
[5]古海锋,张小茜,常增荣,等.HPLC法测定复方益肝灵片中水飞蓟宾的含量[J].中国中医药信息杂志,2008,15(7):51.
 GU Hai-feng,ZHANG Xiao-qian,CHANG Zeng-rong,et al.Determination of Silybin in Fufang Yiganling Tablet by HPLC[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):51.
[6]张茜,金若敏,祝晓雯,等.用肝肾共培养体系研究细胞毒性的方法学考察[J].中国中医药信息杂志,2011,18(11):36.[doi:10.3969/j.issn.1005-5304.2011.11.014]
 ZHANG Qian,JIN Ruo-min,ZHU Xiao-wen,et al.Methodological Study on Cell Toxicity with Liver and Kidney Co-Culture System[J].zhongguo zhongyiyao xinxi zazhi,2011,18(2):36.[doi:10.3969/j.issn.1005-5304.2011.11.014]
[7]于燕燕,狄留庆,黄耀洲,等.双根清脑颗粒质量标准研究[J].中国中医药信息杂志,2007,14(5):46.
 YU Yan-yan,DI Liu-qing,HUANG Yao-zhou,et al.Study on Quality Standard for Shuanggen Qingnao Granules[J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):46.
[8]陈峰.痛清颗粒中芍药苷与葛根素的提取工艺研究[J].中国中医药信息杂志,2007,14(6):46.
 CHEN Feng.Optimization of the Technology of Extracting the Paeoniflorin and Puerarin from Tongqing Granules[J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):46.
[9]郭忠奎,黄凤晖,李欣.高效液相色谱法测定降脂减肥颗粒中葛根素含量[J].中国中医药信息杂志,2007,14(12):46.
 GUO Zhong-kui,HUANG Feng-hui,LI Xin.Determination of Puerarin in Jiangzhijianfei Granules by HPLC[J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):46.
[10]李长天,陈雁飞.葛根素对糖尿病大鼠肾脏糖基化终产物和转化生长因子-β1表达的影响[J].中国中医药信息杂志,2006,13(3):36.
 LI Chang-Tian,CHEN Yan-Fei.Effects of Puerarin on Renal Advanced Glycosylation End Products and Expression of TGF-β1 in Diabetic Rats[J].zhongguo zhongyiyao xinxi zazhi,2006,13(2):36.

备注/Memo

基金项目:2015年安徽理工大学引进人才基金项目(11079);安徽理工大学大学生创新创业训练计划项目(201710361100、201710361103)

更新日期/Last Update:

2019-12-30